GlaxoSmithKline Pharmaceuticals Ltd. started in the year 1924 in India, is one of the most established pharmaceuticals company. At GSK, our mission is to improve the quality of life by enabling people to do more, feel better and live longer.
The GSK India product portfolio includes prescription medicines and vaccines (GSK Biologicals).
  • Prescription medicines range across therapeutic areas such as anti-infective, dermatology,
  gynecology, diabetes, cardiovascular disease and respiratory diseases.
  • Vaccines portfolio includes vaccines against diseases like Hepatitis A and B, Rotavirus, Polio, Chicken   pox, Typhoid and even Cervical Cancer to name a few.
GSK Biologicals, GlaxoSmithKline’s vaccines business, is one of the world’s leading Vaccine companies and a leader in innovation. Over 1300 research scientists are active in the fields of Vaccine research, development and
production with over 30 vaccines approved for marketing and 20 more in
development.
 

Headquartered in Belgium, GSK Biologicals has 13 manufacturing sites (including one in India) strategically positioned around the globe. In 2008,
GSK Biologicals distributed 1.1 billion doses of vaccines to 180 countries in both the developed and the developing world – an average of 3 million
doses a day.

In India GSK Biologicals has over 12 vaccines to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, rotavirus diarrhea, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis.

The most recent innovation is a Vaccine to prevent Cervical Cancer.
• Through its accomplished and dedicated workforce, GSK Biologicals applies its expertise to discover innovative vaccines that contribute to the health and well-being of people of all generations around the world.